Fuminaka Sugauchi

7.0k total citations
79 papers, 3.7k citations indexed

About

Fuminaka Sugauchi is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Fuminaka Sugauchi has authored 79 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hepatology, 71 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Fuminaka Sugauchi's work include Hepatitis C virus research (73 papers), Hepatitis B Virus Studies (66 papers) and Liver Disease Diagnosis and Treatment (52 papers). Fuminaka Sugauchi is often cited by papers focused on Hepatitis C virus research (73 papers), Hepatitis B Virus Studies (66 papers) and Liver Disease Diagnosis and Treatment (52 papers). Fuminaka Sugauchi collaborates with scholars based in Japan, United States and China. Fuminaka Sugauchi's co-authors include Masashi Mizokami, Ryuzo Ueda, Etsuro Orito, Yasuhito Tanaka, Yuzo Miyakawa, Hideaki Kato, Seiji Suzuki, Fuat Kurbanov, Robert G. Gish and Ching‐Lung Lai and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Fuminaka Sugauchi

77 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuminaka Sugauchi Japan 35 3.3k 3.2k 291 284 109 79 3.7k
Stephan Schaefer Germany 30 2.3k 0.7× 1.8k 0.6× 316 1.1× 500 1.8× 89 0.8× 87 3.1k
Stephen Locarnini Australia 23 3.6k 1.1× 3.4k 1.1× 736 2.5× 279 1.0× 53 0.5× 54 4.0k
M. Mizokami Japan 26 2.2k 0.7× 2.3k 0.7× 305 1.0× 202 0.7× 26 0.2× 72 2.7k
Cha‐Ze Lee Taiwan 13 2.2k 0.7× 2.2k 0.7× 202 0.7× 210 0.7× 94 0.9× 18 2.8k
Joerg Petersen Germany 26 2.8k 0.8× 2.5k 0.8× 371 1.3× 420 1.5× 17 0.2× 40 3.2k
Danny Wong Hong Kong 22 1.3k 0.4× 1.2k 0.4× 115 0.4× 231 0.8× 74 0.7× 41 1.7k
Mei Chao Taiwan 18 1.3k 0.4× 1.1k 0.4× 463 1.6× 385 1.4× 19 0.2× 40 1.7k
Julie Lucifora France 27 1.8k 0.6× 1.4k 0.4× 388 1.3× 434 1.5× 39 0.4× 63 2.3k
O. Hantz France 27 2.4k 0.7× 1.8k 0.6× 672 2.3× 807 2.8× 28 0.3× 90 3.1k
Chen Pan China 11 1.6k 0.5× 1.2k 0.4× 314 1.1× 353 1.2× 16 0.1× 32 2.0k

Countries citing papers authored by Fuminaka Sugauchi

Since Specialization
Citations

This map shows the geographic impact of Fuminaka Sugauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminaka Sugauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminaka Sugauchi more than expected).

Fields of papers citing papers by Fuminaka Sugauchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminaka Sugauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminaka Sugauchi. The network helps show where Fuminaka Sugauchi may publish in the future.

Co-authorship network of co-authors of Fuminaka Sugauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminaka Sugauchi. A scholar is included among the top collaborators of Fuminaka Sugauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminaka Sugauchi. Fuminaka Sugauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Tsunamasa, Fuminaka Sugauchi, Yasuhito Tanaka, et al.. (2012). Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of theIL28Bgene. Gut. 62(9). 1340–1346. 18 indexed citations
2.
Watanabe, Tsunamasa, Fuminaka Sugauchi, Shigeru Kusumoto, et al.. (2012). A case report of successful therapy with tenofovir for a multi-drug resistant chronic hepatitis B patient complicated with malignant lymphoma. Kanzo. 53(1). 35–41.
3.
Yotsuyanagi, Hiroshi, Yasuhito Tanaka, Akihiko Saitoh, et al.. (2012). Universal vaccination of hepatitis B virus vaccine. Kanzo. 53(2). 117–130. 2 indexed citations
4.
Kurosaki, Masayuki, Naoya Sakamoto, Manabu Iwasaki, et al.. (2011). Sequences in the interferon sensitivity‐determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG‐interferon plus ribavirin: Data mining analysis. Journal of Medical Virology. 83(3). 445–452. 20 indexed citations
5.
Yuen, Man‐Fung, Danny Ka‐Ho Wong, Yasuhito Tanaka, et al.. (2011). Transmissibility of Hepatitis B Virus (HBV) Infection through Blood Transfusion from Blood Donors with Occult HBV Infection. Clinical Infectious Diseases. 52(5). 624–632. 76 indexed citations
6.
Hiramatsu, Naoki, Masayuki Kurosaki, Naoya Sakamoto, et al.. (2011). Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis. Journal of Gastroenterology. 46(9). 1111–1119. 22 indexed citations
7.
Tanaka, Yasushi, Nao Nishida, Shuhei Hige, et al.. (2010). 726 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC VARIANTS IN THE HLA-DP LOCUS ASSOCIATED WITH CHRONIC HEPATITIS B. Journal of Hepatology. 52. S282–S283. 3 indexed citations
8.
Yoshida, Tatsuya, Shigeru Kusumoto, Atsushi Inagaki, et al.. (2010). Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports. International Journal of Hematology. 91(5). 844–849. 15 indexed citations
9.
10.
Kato, Hideaki, Etsuro Orito, Yuji Nishi, et al.. (2006). A case of acute hepatitis C in which transmission of HCV strain from a patient with chronic hepatitis C was demonstrated. Kanzo. 47(2). 105–112. 2 indexed citations
11.
Tanaka, Yasuhito, Motokazu Mukaide, Etsuro Orito, et al.. (2006). Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. Journal of Hepatology. 45(5). 646–653. 107 indexed citations
12.
Sugauchi, Fuminaka, E ORITO, T Ohno, et al.. (2006). Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatology Research. 36(2). 107–114. 50 indexed citations
13.
Fujiwara, Kei, Yasuhito Tanaka, Etsuro Orito, et al.. (2004). Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus‐related chronic liver disease. Journal of Gastroenterology and Hepatology. 19(12). 1343–1347. 16 indexed citations
14.
Sugauchi, Fuminaka, Etsuro Orito, Takafumi Ichida, et al.. (2003). Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 124(4). 925–932. 171 indexed citations
15.
Tanaka, Yasuhito, Takahisa Furuta, Seiji Suzuki, et al.. (2003). Impact of Interleukin‐1β Genetic Polymorphisms on the Development of Hepatitis C Virus–Related Hepatocellular Carcinoma in Japan. The Journal of Infectious Diseases. 187(11). 1822–1825. 47 indexed citations
16.
Suzuki, Seiji, Fuminaka Sugauchi, Etsuro Orito, et al.. (2003). Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the cote d'Ivoire: Complete genome sequence and phylogenetic relatedness of HBV genotype E. Journal of Medical Virology. 69(4). 459–465. 63 indexed citations
17.
Kubo, Norihiko, Norihiro Furusyo, Yasunori Sawayama, et al.. (2003). A patient in whom only hepatitis B virus (HBV) was thought to have been contracted, by kissing, from a same-sex partner coinfected with HBV and human immunodeficiency virus-1. Journal of Infection and Chemotherapy. 9(3). 260–264. 4 indexed citations
18.
Sugauchi, Fuminaka, Etsuro Orito, Hideaki Kato, et al.. (2002). Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus. Journal of Medical Virology. 69(1). 33–40. 45 indexed citations
19.
Kato, Hideaki, Etsuro Orito, Fuminaka Sugauchi, et al.. (2001). Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers. Journal of Virological Methods. 98(2). 153–159. 77 indexed citations
20.
Sugauchi, Fuminaka, M. Mizokami, Etsuro Orito, et al.. (2000). Molecular Evolutionary Analysis of the Complete Nucleotide Sequence of Hepatitis B Virus (HBV) in a Case of HBV Infection Acquired through a Needlestick Accident. Clinical Infectious Diseases. 31(5). 1195–1201. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Schaefer Breakdown of academic impact, for papers by Stephen Locarnini Breakdown of academic impact, for papers by M. Mizokami Breakdown of academic impact, for papers by Cha‐Ze Lee Breakdown of academic impact, for papers by Joerg Petersen Breakdown of academic impact, for papers by Danny Wong Breakdown of academic impact, for papers by Mei Chao Breakdown of academic impact, for papers by Julie Lucifora Breakdown of academic impact, for papers by O. Hantz Breakdown of academic impact, for papers by Chen Pan
Rankless by CCL
2026